Recruiting NA Median Sternotomy

New treatment option for Median Sternotomy

Official title Liposomal Bupivacaine and Bupivacaine for TTMPB in Median Sternotomy

ClinicalTrials.gov ID: NCT06646172

What this study is testing

What it's testing
In light of the ongoing controversy surrounding the efficacy of bupivacaine liposomes, our study was designed to investigate, for the first time, the differential postoperative analgesic effects between bupivacaine liposomes combined with bupivacaine hydrochloride and bupivacaine hydrochloride alone in transverse thoracic muscle plane block treatment. The aim is to provide evidence-based medical guidance for drug selection in regional block local anesthesia.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 90

You may be able to join if

  • Patients aged 18-90 years;
  • ASA Class I \~ III;
  • Patients undergoing elective median sternotomy.

You likely can't join if

  • Emergency surgery;
  • Re-operation;
  • Coagulation dysfunction;
  • Preoperative left ventricular function was poor (ejection fraction \<35%);
  • Systemic infection or injection site infection;
  • Neuromuscular diseases;
See the full eligibility criteria
Who can join
  • Patients aged 18-90 years;
  • ASA Class I \~ III;
  • Patients undergoing elective median sternotomy.
What rules you out
  • Emergency surgery;
  • Re-operation;
  • Coagulation dysfunction;
  • Preoperative left ventricular function was poor (ejection fraction \<35%);
  • Systemic infection or injection site infection;
  • Neuromuscular diseases;
  • Mental illness;
  • Dependence on psychotropic drugs;
  • Allergic to bupivacaine liposomes and bupivacaine;
  • Patients have participated in previous trials or have been determined by a surgeon or anesthesiologist to be unsuitable for randomization;
  • Failure to obtain written informed consent from the patient or his/her representative

The study team makes the final eligibility decision.

Where it's taking place

  • Wuhan, Hubei, China

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.